Legend Capital has returned to invest in the metabolic and immunological disease-focused biotechnology developer, having backed its series A round two years ago.

MIT’s cancer and infectious disease therapy spinout has added $40m to a round that will support the progression of its lead asset into the clinic.

The JD.com, Shanghai Pharma and SoftBank China Venture Capital-backed O2O medical services operator, has secured fresh funding from investors including Sinocare.

The Qilu Pharmaceutical-backed cancer, immune disorder and metabolic disease drug developer has closed a series B round led by Lilly Asia Ventures.

The Livzon-backed cancer and infectious disease therapy developer has added $40m to a round that will support the progression of its lead candidate toward clinical trials.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The DevOps platform provider has raised $117m to date after Salesforce Ventures and Insight Partners co-led its latest funding round.

US-based startup developing a three-dimension and virtual reality platform for trade workers has raised $18m.

GV (formerly known as Google Ventures) and real estate developer Lennar Corporation joined the B round.

The automotive vision technology developer raised $48.9m in a round featuring Continental, Toyota AI Ventures, BMW i Ventures, Robert Bosch Venture Capital and Fluxunit – Osram Ventures.